Search

everythinglearnresearchcommunity

for

Search:↓

An imbalanced scalp microbiome may worsen alopecia areata severity and inflammation, but treatment can partially restore balance.

The COVID-19 pandemic led to an increase in untreated hair diseases and showed the importance of teledermatology.

Sebaceous glands play a key role in skin health, immunity, and various skin diseases.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

Trichoscopy helps better understand and manage alopecia areata, improving patient outcomes.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Early treatment of acne is crucial to prevent scarring and psychological effects.

Avicennia marina shows potential to treat Hepatitis C by targeting key proteins.

Timely treatment of eosinophilic asthma in rheumatic disease patients can prevent organ damage.

Early recognition and thyroid evaluation are crucial for managing diffuse alopecia areata linked to autoimmune thyroid disease.

Extracellular vesicles can both worsen and help treat age-related diseases and are useful for early diagnosis.

More precise, personalized therapies are needed for autoimmune diseases.

Lupeol shows promise for hair growth but needs better absorption and safety testing.

JAK inhibitors show promise for treating skin disorders like alopecia, eczema, and psoriasis.

Patients with RASopathies are at risk for autoimmune disorders and should be routinely screened.

Metabolic syndrome is linked to skin diseases, requiring integrated treatment and monitoring.

Recognizing LET and AITD can help diagnose SLE early for better treatment.

Thyroid disorders can cause skin issues in children, so early detection and screening are important.

Autoimmune markers may help diagnose and manage PCOS.

Extracellular vesicles can worsen Alzheimer's but also offer potential for diagnosis and treatment.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

New treatments for hair loss show promise with advanced therapies and better targeting.

Cannabinoids may help treat various skin conditions.

New treatments for alopecia show promise in restoring hair growth by targeting immune and hormonal factors.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

Scientists are still unsure what triggers the immune system to attack hair follicles in Alopecia areata.

Vitamin D might be involved in the development of alopecia areata and could help in its treatment.

The MBTPS2 gene variant c.970+5G>A is a common mutation causing IFAP syndrome.

The report expanded knowledge of MBTPS1-related disorders by identifying new symptoms.

A new syndrome was linked to two new genetic changes in the MBTPS1 gene in a 14-year-old girl.